Commercial Insight: Cytotoxic Therapies - Drug Launches in Rare Indications to Offset the Decline in Cytotoxic Sales Now Available at Reportsandreports
Growth of cytotoxics will remain static over the forecast period with a CAGR of -0.1%.
View full press release